the premarket is above our support the orang line , we should hold to confirm the price continuation till the first profit taking , then if we broke this level we going to have a test for the other 2 profit taking .
remember the profit taking area is area of possible rejection and short coming in , the only way to find out that we will continue to go up, is...
Lots of interesting setups with Pharma sector. This one too.
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
$SYRS Target 10.92 for 66.21%
Or double position at 2.88
Nothing has changed here... I'm just charting and organizing my portfolio ATM.
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed...
$SYRS Target 8.81 for 27.68%
Or next add level is at 4.99
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before...
Follow me and smash that like button! Bio-pharmaceutical company aims to treat cancer and genetic diseases. Not the investment. Please do your own due diligence.
$SYRS Target 9.22 for 26.13%
Or next add level is at 5.40
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before...
$SYRS Target 9.89 for 23.93%
Or next add level is at 6.07
Added a little here... Next add at 6.07 is pretty close so let's hope for some more upward action.
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build...
ADDED $SYRS Target 10.12 for 23.26%
Or next add level is at 6.30
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups...
$SYRS Target 10.32 for 22.71%
Or next add level is at 6.50
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. ...
$SYRS Target 10.44 for 22.39%
Or DOUBLE POSITION at 6.62
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I...
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Syros Pharmaceuticals made a big move up this morning, but has retraced to support at 7.08 (not reflected on the chart yet for some reason). It may bounce higher later today.
